You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Second primary site disease stage IV

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

Recruiting
  • Epithelial Ovarian Carcinoma Stage III
  • +5 more
  • nab-paclitaxel combined with carboplatin
  • Guangzhou, Guangdong, China
  • +10 more
Feb 19, 2023

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

Gastric Adenocarcinoma Trial in Saint-Herblain (Preoperative Chemotherapy, Surgery, Postoperative chemo)

Recruiting
  • Gastric Adenocarcinoma
  • Preoperative Chemotherapy
  • +2 more
  • Saint-Herblain, France
    Ico - Site Gauducheau - St Herblain
Mar 14, 2022

NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • primary tumour radiotherapy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 6, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib 75 mg, Docetaxel 75

Completed
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Selumetinib 75 mg
  • +3 more
  • Santa Monica, California
  • +50 more
Nov 22, 2022

NSCLC, Bone Metastases Trial in France (Denosumab-nivolumab combination)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Bone Metastases
  • Denosumab-nivolumab combination
  • Aix-en-Provence, France
  • +26 more
Jul 19, 2022

Renal Impairment Trial in Orlando, Saint Paul (MK-3402)

Terminated
Has Results
  • Renal Impairment
  • Orlando, Florida
  • +1 more
Apr 5, 2022

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Palliative Primary Tumor Resection in Minimally Symptomatic

Recruiting
  • Colorectal Neoplasms
  • +12 more
  • Moscow, Russian Federation
    Ryzhikh National Medical Research Center of Coloproctology
Apr 2, 2022

Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Ovarian Mass Trial in United States (Laboratory

Completed
  • Fallopian Tube Serous Adenocarcinoma
  • +18 more
  • Laboratory Biomarker Analysis
  • BMN 673
  • Houston, Texas
  • +5 more
Feb 11, 2022

Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

Recruiting
  • Malignant Digestive System Neoplasm
  • +12 more
  • Computed Tomography
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Treating Patients With Stage IV Breast Cancer

Active, not recruiting
  • Central Nervous System Metastases
  • +15 more
  • hyperfractionated radiation therapy
  • +2 more
  • North Chicago, Illinois
    University of Chicago
Dec 6, 2021

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting
  • Metastatic Fallopian Tube Carcinoma
  • +11 more
  • Phoenix, Arizona
  • +13 more
Dec 2, 2022

Stage IV Gastric Cancer With Metastasis Trial (Camrelizumab; Nab-paclitaxel; S-1)

Not yet recruiting
  • Stage IV Gastric Cancer With Metastasis
  • Camrelizumab; Nab-paclitaxel; S-1
  • (no location specified)
Jul 5, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Blood and Tissue Samples From Locally Recurrent or Metastatic

Recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2021

NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer NSCLC
  • Bonita Springs, Florida
  • +67 more
Nov 15, 2022

Gastric Cancer Stage IV, Peritoneal Metastases Trial in Shanghai (sintilimab, paclitaxel and S-1)

Recruiting
  • Gastric Cancer Stage IV
  • Peritoneal Metastases
  • sintilimab, paclitaxel and S-1
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Jan 10, 2022

Metastatic NSCLC Trial in France (Pembrolizumab before randomization, Chemotherapy, Pemetrexed)

Recruiting
  • Metastatic NSCLC
  • Pembrolizumab before randomization
  • +3 more
  • Aix-en-Provence, France
  • +37 more
Jul 26, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial in Worldwide (Pembrolizumab)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • Pembrolizumab
  • Torrance, California
  • +26 more
Oct 20, 2022

Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

Recruiting
  • Sarcoma, Synovial
  • +8 more
  • CYCLOPHOSPHAMIDE and FLUDARABIN
  • +3 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 15, 2022

Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)

Not yet recruiting
  • Liver Diseases
  • +27 more
  • Liver Transplantation
  • Murcia, Spain
    Felipe Alconchel
Feb 24, 2022